Published in Genes Immun on May 01, 2005
IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS One (2009) 1.09
Pathogenesis of Systemic Sclerosis. Front Immunol (2015) 0.89
Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement. Rheumatol Int (2008) 0.78
Genetics, Epigenetics, and Genomics of Systemic Sclerosis. Rheum Dis Clin North Am (2015) 0.76
Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients. Mol Vis (2012) 0.75
Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density--a clinical research center study. J Clin Endocrinol Metab (1995) 1.72
Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome. Ann Rheum Dis (2001) 1.68
Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides. Lancet (1979) 1.67
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant (2003) 1.55
Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford) (2008) 1.53
Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Ann Rheum Dis (2008) 1.48
Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum (1998) 1.45
Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes. J Infect Dis (1986) 1.43
Massive pericardial effusion in scleroderma: a review of five cases. Br J Rheumatol (1995) 1.42
Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine. N Engl J Med (1986) 1.36
Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med (1997) 1.29
Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest (1984) 1.28
A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci (2001) 1.25
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol (2008) 1.22
The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect (1999) 1.20
Genes associated with the G2m(23) immunoglobulin allotype regulate the IgG subclass responses to Haemophilus influenzae type b polysaccharide vaccine. J Infect Dis (1988) 1.16
Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. J Clin Periodontol (1998) 1.10
Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol (1999) 1.07
Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol (1999) 1.07
Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. J Clin Invest (1981) 1.04
Immunoglobulin allotypes and immune response to meningococcal group B polysaccharide. J Clin Invest (1981) 1.03
Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol (1997) 1.02
Gm and Km frequencies in a Portuguese population. Hum Genet (1982) 1.02
Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease. J Immunogenet (1985) 1.02
Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Cornea (2001) 1.02
Relation of age, race, and allotype to immunoglobulin subclass concentrations. Pediatr Res (1985) 1.02
Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford) (2001) 1.02
Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes. Clin Exp Immunol (2011) 1.01
Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum (1985) 0.99
Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J Immunol (1994) 0.98
Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol (2009) 0.97
Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis (2004) 0.96
Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann Rheum Dis (2008) 0.94
Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol (2000) 0.94
HLA antigens and immunoglobulin allotypes in patients with malignant melanoma. Hum Immunol (1981) 0.93
Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients. Int J Cancer (1984) 0.92
Heterozygosity at Gm loci associated with humoral immunity to osteosarcoma. J Exp Med (1982) 0.92
Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology (Oxford) (2007) 0.91
Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations. Arthritis Rheum (2001) 0.91
Significant differences in GM allotype frequencies between two sympatric tribes with markedly differential susceptibility to malaria. Parasite Immunol (2007) 0.91
Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum (1999) 0.91
Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients. J Immunol (1994) 0.91
Interactive effect of Gm and Km allotypes on cellular immune responses to streptococcal cell wall antigen. Exp Clin Immunogenet (1987) 0.90
T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum (2000) 0.90
Failure of linguistic relationships to predict genetic distances between the Waiãpi and other tribes of lower Amazonia. Am J Phys Anthropol (1983) 0.90
Two unlinked genetic loci interact to control the human immune response to type III group B streptococcal antigen. J Immunogenet (1984) 0.90
Familial clustering of scleroderma spectrum disease. Am J Med (1988) 0.90
Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet (1995) 0.89
Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev (1979) 0.88
Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. Clin Immunol Immunopathol (1996) 0.88
Host and bacterial factors associated with Haemophilus influenzae type b disease in Minnesota children vaccinated with type b polysaccharide vaccine. J Infect Dis (1989) 0.88
Further blood genetic studies on Amazonian diversity--data from four Indian groups. Ann Hum Biol (1994) 0.87
Preferential synthesis of the G1m(1) allotype of IgG1 in the central nervous system of multiple sclerosis patients. Science (1981) 0.87
Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum (1991) 0.87
Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak. Pediatrics (1986) 0.87
The effect of race, smoking and immunoglobulin allotypes on IgG subclass concentrations. J Periodontal Res (1997) 0.87
TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol (1999) 0.87
CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus (2004) 0.86
Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum (1998) 0.86
Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant (2006) 0.84
Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51. Clin Exp Rheumatol (2008) 0.84
HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens (2000) 0.84
Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies. Eur J Neurol (2013) 0.83
Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet (1997) 0.83
Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap. Rheumatology (Oxford) (2002) 0.83
Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Lupus (2007) 0.83
Genetic segregation analyses of serum IgG2 levels. Am J Hum Genet (1996) 0.83
Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production. Ann Rheum Dis (1998) 0.83
Associations between six classical HLA loci and rheumatoid arthritis: a comprehensive analysis. Tissue Antigens (2012) 0.83
The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients. Clin Exp Immunol (1997) 0.83
IL-1 gene polymorphisms, secretion in gingival crevicular fluid, and speed of human orthodontic tooth movement. Orthod Craniofac Res (2009) 0.82
HLA, Gm, and Km polymorphisms and immunity to infectious diseases in South Amerinds. Exp Clin Immunogenet (1995) 0.82
Gm allotype associated resistance and susceptibility to alopecia areata. Clin Exp Immunol (1984) 0.82
Characterization of autoreactive T-cell clones to myeloperoxidase in patients with microscopic polyangiitis and healthy individuals. Clin Exp Rheumatol (2009) 0.82
Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus (2008) 0.81
Genetic variation within a linguistic group: Apalai-Wayana and other Carib tribes. Am J Phys Anthropol (1988) 0.81
Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies. Clin Exp Rheumatol (2005) 0.81
Alpha-I-antitrypsin (Pi) phenotypes in Lyon, France: departure from Hardy-Weinberg equilibrium. Clin Genet (1977) 0.81
Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype. J Infect Dis (1988) 0.81
[Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis]. Ryumachi (1997) 0.81
Nodular regenerative hyperplasia of the liver in a patient with systemic sclerosis. Clin Rheumatol (1996) 0.80
The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation. Clin Exp Immunol (2004) 0.80
Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism. Rheumatology (Oxford) (2005) 0.80
Initial predictors of survival in patients with systemic sclerosis (scleroderma). Keio J Med (1992) 0.80
Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome. Intern Med (1996) 0.80
Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects. Eur J Neurol (2005) 0.80
Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity. Lupus (2012) 0.80
Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus. Lupus (1995) 0.80
Gm allotypes in blacks with systemic lupus erythematosus. Hum Immunol (1983) 0.80
Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. Clin Exp Immunol (1992) 0.80
Anticentromere antibody and immunoglobulin allotypes in scleroderma. Arch Dermatol (1985) 0.79
Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus. Rheumatol Int (2006) 0.79
Linkage relationship between variable and constant region allotypic determinants of human immunoglobulin heavy chains. Nature (1980) 0.79
Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered (1999) 0.79
IgG allotypes and subclasses in Norwegian patients with multiple sclerosis. J Neurol Sci (2000) 0.79
Anti-cardiolipin-beta2-GPI complex antibodies in idiopathic thrombocytopenic purpura. Intern Med (1998) 0.79
IgG heavy-chain (Gm) allotypes in demyelinating polyneuropathy associated with MAG-binding monoclonal IgM autoantibodies. Ann Neurol (1987) 0.79